World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
128
Citations
161259
World Ranking
431
National Ranking
275

Medicine

D-Index
129
Citations
161854
World Ranking
2516
National Ranking
1417

Overview

Joel S. Parker is affiliated with the University of North Carolina at Chapel Hill in the United States. The primary focus of their research lies in Medicine and Biochemistry, Genetics and Molecular Biology. Within these fields, they have contributed extensively to subfields such as Molecular Biology, Oncology, Cancer Research, Pulmonary and Respiratory Medicine, and Genetics.

Their scientific work primarily explores important topics including Cancer Genomics and Diagnostics, HER2/EGFR in Cancer Research, Breast Cancer Treatment Studies, Cancer Immunotherapy and Biomarkers, Advanced Breast Cancer Therapies, Cancer Cells and Metastasis, as well as Monoclonal and Polyclonal Antibodies Research.

Joel S. Parker's publication record includes notable papers such as:

  • The molecular portraits of breast tumors are conserved across microarray platforms, 2020, UNC Libraries
  • Radiation-related genomic profile of papillary thyroid carcinoma after the Chernobyl accident, 2021, Science
  • Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes, 2023, Journal of Clinical Oncology
  • A selective WDR5 degrader inhibits acute myeloid leukemia in patient-derived mouse models, 2021, Science Translational Medicine
  • Development and validation of the new HER2DX assay for predicting pathological response and survival outcome in early-stage HER2-positive breast cancer, 2022, EBioMedicine

The frequent coauthors collaborating with Parker include:

  • Charles M. Perou
  • Aleix Prat
  • Laia Paré
  • Fara Brasó-Maristany
  • Patricia Villagrasa

The primary venues where Joel S. Parker's research has been published consist of:

  • UNC Libraries
  • Cancer Research
  • Clinical Cancer Research
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Nature Communications

Best Publications

  • Comprehensive molecular portraits of human breast tumours

    Daniel C. Koboldt;Robert S. Fulton;Michael D. McLellan;Heather Schmidt

  • The cancer genome atlas pan-cancer analysis project

    John N Weinstein;John N Weinstein;Eric A. Collisson;Gordon B Mills;Kenna R Mills Shaw;Kenna R Mills Shaw

  • Repeated observation of breast tumor subtypes in independent gene expression data sets

    Therese Sørlie;Robert Tibshirani;Joel Parker;Trevor Hastie

  • Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes

    Joel S. Parker;Michael Mullins;Maggie C.U. Cheang;Samuel Leung

  • Integrated genomic characterization of endometrial carcinoma

    Gad Getz;Stacey B. Gabriel;Kristian Cibulskis;Eric Lander

  • Comprehensive molecular profiling of lung adenocarcinoma: The cancer genome atlas research network

    Eric A. Collisson;Joshua D. Campbell;Angela N. Brooks;Angela N. Brooks;Alice H. Berger

  • Comprehensive genomic characterization of head and neck squamous cell carcinomas

    Michael S. Lawrence;Carrie Sougnez;Lee Lichtenstein;Kristian Cibulskis

  • The Immune Landscape of Cancer

    Vésteinn Thorsson;David L Gibbs;Scott D Brown;Denise Wolf

  • Comprehensivemolecular characterization of clear cell renal cell carcinoma

    Chad J. Creighton;Margaret Morgan;Preethi H. Gunaratne;Preethi H. Gunaratne;David A. Wheeler

  • Comprehensive molecular characterization of urothelial bladder carcinoma

    John N Weinstein;Rehan Akbani;Bradley McIntosh Broom;Wenyi Wang

  • Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas.

    Daniel J. Brat;Roel G.W. Verhaak;Kenneth D. Aldape;W. K.Alfred Yung

  • Oncogenic Signaling Pathways in The Cancer Genome Atlas

    Francisco Sanchez-Vega;Marco Mina;Joshua Armenia;Walid K. Chatila

  • Pan-cancer analysis of whole genomes

    Peter J. Campbell;Gad Getz;Jan O. Korbel;Joshua M. Stuart

  • Genomic Classification of Cutaneous Melanoma

    Rehan Akbani;Kadir C. Akdemir;B. Arman Aksoy;Monique Albert

  • The Molecular Taxonomy of Primary Prostate Cancer

    Adam Abeshouse;Jaeil Ahn;Rehan Akbani;Adrian Ally

  • Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer

    Maggie C. U. Cheang;Stephen K Chia;David Voduc;Dongxia Gao

  • Integrated Genomic Characterization of Papillary Thyroid Carcinoma

    Nishant Agrawal;Rehan Akbani;B. Arman Aksoy;Adrian Ally

  • Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer

    Aleix Prat;Joel S Parker;Olga Karginova;Cheng Fan

  • The Cancer Genome Atlas Pan-Cancer analysis project

    Kyle Chang;Chad J Creighton;Caleb Davis;Lawrence Donehower

  • The Molecular Taxonomy of Primary Prostate Cancer

    Adam Abeshouse;Jaeil Ahn;Rehan Akbani;Adrian Ally

Frequent Co-Authors

Charles M. Perou
Charles M. Perou University of North Carolina at Chapel Hill
Katherine A. Hoadley
Katherine A. Hoadley University of North Carolina at Chapel Hill
Gad Getz
Gad Getz Broad Institute
Lisa A. Carey
Lisa A. Carey University of North Carolina at Chapel Hill
Julie M. Gastier-Foster
Julie M. Gastier-Foster Baylor College of Medicine
Matthew D. Wilkerson
Matthew D. Wilkerson Uniformed Services University of the Health Sciences
Andrew D. Cherniack
Andrew D. Cherniack Broad Institute
W. Kimryn Rathmell
W. Kimryn Rathmell Vanderbilt University Medical Center
Rameen Beroukhim
Rameen Beroukhim Harvard University
Matthew Meyerson
Matthew Meyerson Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Joel S. Parker

Trending Scientists

Recently Published Articles